DR. JOSEPH M PASCUZZO DO NPI 1538244314

NPI Details

DR. Joseph M Pascuzzo, DO is a hematology and oncology internal medicine in Fresno, CA with 45 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Joseph M Pascuzzo, DO NPI is 1538244314. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
Graduation Year:1981

The provider's business location address is:

7130 N MILLBROOK AVE
FRESNO, CA
ZIP 93720-347
Phone: (559) 326-1222
Fax: (559) 326-1225

The NPI 1538244314 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
• Injection, atezolizumab, 10 mg (HCPCS:J9022)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Red blood count, automated test (HCPCS:85045)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Blood test, clotting time (HCPCS:85610)
• Magnesium level (HCPCS:83735)
• Uric acid level, blood (HCPCS:84550)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Urinalysis, manual test (HCPCS:81002)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Unclassified drugs (HCPCS:J3490)
• Electrophoresis, laboratory testing technique (HCPCS:82664)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Phosphate level (HCPCS:84100)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Ct scan of chest with contrast (HCPCS:71260)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Stool analysis for blood, by peroxidase activity (HCPCS:82272)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Ct scan of chest without contrast (HCPCS:71250)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Declotting of central venous tube (HCPCS:36593)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Drawing of blood for a medical problem (HCPCS:99195)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Calcium level, total (HCPCS:82310)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Unclassified biologics (HCPCS:J3590)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Extended inpatient or observation hospital service, first hour (HCPCS:99356)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection, meperidine hydrochloride, per 100 mg (HCPCS:J2175)
• Injection, promethazine hcl, up to 50 mg (HCPCS:J2550)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)

The enumeration date for this NPI number is 10/27/2006 and was last updated on 10/9/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.